MeSH term
Frequency | Condition_Probility | Animals | 19 | 0.0 |
*Cell Transformation, Neoplastic | 2 | 0.0 |
Humans | 45 | 0.0 |
Research Support, Non-U.S. Gov't | 35 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Base Sequence | 9 | 0.0 |
Binding Sites | 4 | 0.0 |
COS Cells | 2 | 0.0 |
Cell Line | 12 | 0.0 |
DNA/genetics | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Hela Cells | 7 | 0.0 |
Mice | 11 | 0.0 |
Models, Biological | 2 | 0.0 |
Protein Structure, Tertiary | 8 | 0.0 |
Repressor Proteins/chemistry/genetics/*metabolism | 3 | 6.0 |
*CpG Islands | 4 | 5.0 |
DNA Methylation | 17 | 2.0 |
DNA-Binding Proteins/*biosynthesis/genetics | 2 | 2.0 |
Gene Deletion | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
RNA, Neoplasm/biosynthesis | 2 | 1.0 |
Transcription, Genetic | 6 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Chromatin/metabolism | 3 | 1.0 |
DNA-Binding Proteins/*chemistry/metabolism | 2 | 2.0 |
Immunoblotting | 2 | 0.0 |
Luciferases/metabolism | 3 | 0.0 |
Methylation | 2 | 0.0 |
Precipitin Tests | 5 | 0.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Protein Binding | 8 | 0.0 |
RNA, Messenger/metabolism | 6 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Time Factors | 3 | 0.0 |
*Transcription, Genetic | 6 | 0.0 |
Transfection | 10 | 0.0 |
Male | 7 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 4 | 0.0 |
Gene Expression Regulation, Neoplastic | 7 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Repressor Proteins/*genetics/metabolism | 3 | 4.0 |
*Chromosomal Proteins, Non-Histone | 9 | 4.0 |
*DNA Methylation | 14 | 2.0 |
DNA-Binding Proteins/*genetics | 7 | 0.0 |
Repressor Proteins/*genetics | 3 | 1.0 |
Genome | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Cell Differentiation | 2 | 0.0 |
Histone Deacetylases/*metabolism | 2 | 1.0 |
*Repressor Proteins | 6 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
*Gene Silencing | 4 | 2.0 |
Repressor Proteins/chemistry/*metabolism | 2 | 9.0 |
Transcription, Genetic/*genetics | 2 | 1.0 |
Amino Acid Sequence | 9 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Histone Deacetylases/metabolism | 3 | 3.0 |
Hydroxamic Acids/pharmacology | 2 | 1.0 |
Molecular Sequence Data | 13 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
*Zinc Fingers | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Acetylation | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
CpG Islands | 7 | 2.0 |
Histones/*metabolism | 2 | 1.0 |
Adult | 2 | 0.0 |
Aged | 2 | 0.0 |
CpG Islands/*genetics | 4 | 4.0 |
DNA (Cytosine-5-)-Methyltransferase/*genetics | 2 | 7.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Female | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 4 | 0.0 |
Fluorescent Antibody Technique, Indirect | 3 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
Comparative Study | 4 | 0.0 |
*Endodeoxyribonucleases | 2 | 7.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Genetic Vectors | 3 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Mutation | 3 | 0.0 |
Sulfites/pharmacology | 3 | 9.0 |
Plasmids | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |